Drug companies are on the edge of stopping production of "fist drugs"
-
Last Update: 2014-07-14
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In recent years, "the company has several top-notch pharmaceutical products with Chinese herbal medicine" Shandou root "as the main medicine Due to the near depletion of wild resources, the supply of raw materials has been" red light " If the large-scale cultivation can no longer be realized, these top pharmaceutical products will face the offline risk " He Xiurong, the former chairman of Guizhou hengba Pharmaceutical Co., Ltd., was very anxious In order to ensure the supply of pharmaceutical raw materials, many local pharmaceutical companies have planted their own Chinese herbal medicines, hoping to solve the urgent problem However, due to the confusion of provenance introduction, some medicinal materials have poor stress resistance, unstable efficacy and uneven quality, which can not meet the production demand of pharmaceutical enterprises, resulting in many pharmaceutical enterprises falling into the edge of existing "fist drugs" shutdown.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.